ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Influence of Baseline Immunosuppresion on Renal Function and Clinical Outcomes in Liver Transplantation, The

    A. Mardis, D. Taber, H. Meadows, N. Pilch, J. Fleming, C. Jordan, K. Morbitzer, C. Makowski, J. McGillicuddy, C. Bratton, K. Chavin, P. Baliga

    Pharmacy, MUSC, Charleston, SC; Surgery, MUSC, Charleston, SC

    Background: Preserving renal function in liver transplantation has become paramount to improving long-term survival. However, there are limited definitive studies comparing different immunosuppression (IS) regimens…
  • 2013 American Transplant Congress

    Theaflavin (TF) Ameliorates Kidney Ischemia-Reperfusion Injury in Mice

    J. Hou, T. Sato, Z. Fang, Q. Ding, X. Li

    National Institute for Child Health and Development, Tkyo, Japan; Huashan Hospital, Fudan University, Shanghai, China

    Renal ischemia reperfusion injury (IRI) is a major factor responsible for acute renal failure (ARF). ARF is a common clinical morbidity, which can occur as…
  • 2013 American Transplant Congress

    Portrait of CAD with IF-TA Development Post Kidney Transplantation. Proteomics as Noninvasive Biomarkers

    R. Gehrau, D. Maluf, H. Cathro, A. King, J. Suh, K. Brayman, D. Ladie, V. Mas

    UVA, Charlottesville; VCU, Richmond

    Background: Chronic allograft dysfunction (CAD) with interstitial fibrosis-tubular atrophy (IFTA) post kidney transplantation (KT) is one of the most common causes of graft loss. This…
  • 2013 American Transplant Congress

    Liver Grafts from Anti-HBc Positive Donors for Anti-HBc Negative Recipients in Liver Transplantation Using Combined Antiviral Prophylaxis

    A. Brandl, P. Stolzlechner, S. Eschertzhuber, F. Aigner, I. Graziadei, W. Vogel, S. Schneeberger, J. Pratschke, R. Öllinger

    Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Tyrol, Austria; Department of Anesthesia and Intensive Care Medicine, Medical University Innsbruck, Innsbruck, Tyrol, Austria; Departments of Internal Medicine II (Gastroenterology and Hepatology), Medical University Innsbruck, Innsbruck, Tyrol, Austria

    IntroductionDue to organ shortage the use of so called „marginal livers“ is increasing in deceased donor liver transplantation. Herein we investigate the long term outcome…
  • 2013 American Transplant Congress

    Regulatory Molecular Profile of Early Ischemia Reperfusion Injury after Liver Transplantation

    R. Gehrau, V. Mas, C. Dumur, J. Suh, L. Murray, B. Kane, D. Maluf

    UVA, Charlottesville; VCU, Richmond

    Background: Graft function post liver transplantation (LT) depends on donor quality and the degree of hepatocyte post-ischemia reperfusion injury (IRI). Hereby, we evaluated early-deregulated molecular…
  • 2013 American Transplant Congress

    Examination of Infectious Complications with Plasmapheresis in Combination with Anti-Thymocycte Globulin for the Treatment of Acute Rejection

    A. Hulbert, A. Rajab, J. Von Visger, H. Winters

    Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH; Transplant Surgery, The Ohio State University Wexner Medical Center, Columbus, OH; Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH

    Background: Due to the complex nature of acute rejection (AR), multiple therapeutic modalities may be employed. The benefit of plasmapheresis (PP) with anti-thymocyte globulin (ATG)…
  • 2013 American Transplant Congress

    Potential Contributions to the Direct Pathway by Donor Dendritic Cells at Vascularized Graft

    T. Ueno, M. Yeung, K. Jun, M. McGrath, N. Da Silva, T. Ikeda, N. Najafian, B. Sylvie, D. Brown, A. Yun, R. Weissleder, M. Sayegh

    CSB, Massachusetts General Hospital, Boston, MA; Transplantation Research Center, Renal, Brigham and Women's Hospital, Boston, MA; Wellman Center, Dermatology, Massachusetts General Hospital, Boston, MA; Critical Care Medicine, Tokyo Medical University Hospital, Hchioji, Tokyo, Japan

    It is widely known that resident dendritic cells (DC) in tissue, or donor DC (dDC), are able to traffic to the secondary lymphoid tissues of…
  • 2013 American Transplant Congress

    Complement-Activating DSA: Which Assay in Which Setting?

    C. Lawrence, M. Willicombe, P. Brookes, E. Santos-Nunez, C. Roufosse, A. Warrens, D. Taube

    Imperial College Renal & Transplant Centre, Hammersmith Hospital, London, United Kingdom

    The presence of pre-formed and de novo donor specific antibodies [DSA] are associated with an increased incidence of antibody mediated rejection [AMR] and graft loss…
  • 2013 American Transplant Congress

    Regulatory Effect of microRNAs in Ischemia Reperfusion Injury Post Liver Transplantation: Looking for Therapeutic Targets

    R. Gehrau, V. Mas, C. Dumur, J. Suh, M. Wardus, B. Kane, S. Luebbert, D. Maluf

    Surgery, Division of Transplantation, University of Virginia, Charlottesville, VA; Pathology, VCU, Richmond, VA

    Background: MicroRNAs (miRNA) exert regulatory effects in biological mechanisms and had been recently targeted for therapeutic interventions. In Liver Transplantation (LT), graft function post reperfusion…
  • 2013 American Transplant Congress

    Complement-Activating Low-Level Preformed Donor-Specific Antibodies Detected by C1qScreen™ Predict Early Antibody-Mediated Rejection in Renal Allografts

    C. Lawrence, M. Willicombe, P. Brookes, C. Clarke, E. Santos-Nunez, C. Roufosse, A. Warrens, D. Taube

    Imperial College Renal & Transplant Centre, Hammermsith Hospital, London, United Kingdom

    Renal transplant recipients with negative CDC [CDC-XM] and Flow crossmatch [Flow-XM] and low level DSA [by Luminex] have worse outcomes than non-sensitized patients. The aim…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences